Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Clinical evaluation of PolyDeep, a computer-aided detection system: a multicenter randomized tandem colonoscopy trial

  • Davila Piñón, Pedro
  • Díez Martín, Astrid Irene
  • Nogueira Rodríguez, Alba
  • Domínguez Carbajales, Rubén
  • Fernández Riverola, Florentino
  • Zarraquiños, Sara
  • de Castro, Luisa
  • Herrero, Jesús
  • Fernández, Nereida
  • Vega, Pablo
  • Remedios, David
  • Martínez, Alfonso
  • Puga, Manuel
  • Alonso, Sara
  • Pin, Noel
  • García Morales, Natalia
  • Rivas, Laura
  • Ledo, Alejandro
  • Macenlle, Ramiro
  • Cid, Lucia
  • Rodríguez, Antonio
  • Soto, Santiago
  • Baiocchi, Franco
  • Pérez Medrano, Indhira
  • Sánchez, Eloy
  • González Peña, Daniel
  • Reboiro Jato, Miguel
  • López Fernández, Hugo
  • Cubiella, Joaquín
Background/Objectives: Computer-aided detection (CADe) systems are increasingly used in endoscopy to enhance lesion recognition. PolyDeep is a CADe/x tool previously assessed in an observational study. The aim of our study is to determine if PolyDeep-assisted colonoscopy reduces the adenoma miss rate (AMR) compared with conventional colonoscopy. Methods: We carried out a multicenter randomized controlled trial with a tandem colonoscopy design in participants from a colorectal cancer screening program (positive fecal immunochemical test-FIT or surveillance). Expert endoscopists performed all colonoscopies, and patients were allocated to groups by a computer-generated sequence. The primary endpoint was AMR; secondary endpoints included polyp miss rate (PMR), serrated lesion miss rate (SLMR) and advanced polyp miss rate (APMR). Results: From May to November 2023, we recruited 260 patients and excluded 20, leaving 240 for analysis. Baseline characteristics were balanced between groups (62.1% male; mean age 62.3 ± 6.5 years; 65.8% FIT-positive; mean first withdrawal time 13:38 ± 08:07 min; mean second withdrawal time 07:50 ± 03:38 min; lesion detection rate 76.6%; mean polyps per patient 3.4 ± 3.1). We did not find statistically significant differences between PolyDeep-assisted and conventional colonoscopy groups in AMR (21.3% vs. 18.1%, p = 0.5), PMR (21.8% vs. 20.3%, p = 0.7), SLMR (23.4% vs. 25.6%, p = 0.9) or APMR (7.3% vs. 11.3%, p = 0.5). In the subgroup analysis according to indication, we did not find any statistically significant differences. Conclusions: In the context of a CRC screening program, PolyDeep-assisted colonoscopy did not reduce AMR., Agencia Estatal de Investigación | Ref. DPI2017-87494, Agencia Estatal de Investigación | Ref. PDC2021-121644-I00, Instituto de Salud Carlos III | Ref. PI21/01771, Instituto de Salud Carlos III | Ref. CD22/00087, Instituto de Salud Carlos III | Ref. INT22/00009, Instituto de Salud Carlos III | Ref. FI22/00203, Xunta de Galicia | Ref. ED431G 2019/06, Xunta de Galicia | Ref. ED431C 2022/03, Xunta de Galicia | Ref. ED481B 2023/005, Asociación Española de Gastroenterología
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Comparative analysis of capture methods for genomic profiling of circulating tumor cells in colorectal cancer

  • Fernandes Alves, Joao Miguel
  • Estevez Gomez, Nuria
  • Valecha , Monica Vishnu
  • Prado López, Sonia
  • Tomás López, Laura
  • Alvariño Sanjurjo, Pilar
  • Silva Piñeiro, Roberto
  • Muinelo Romay, Laura
  • Mondelo Macía, Patricia
  • Salgado, Mercedes
  • Iglesias Gómez, Agueda
  • Codesido Prada, Laura
  • Cubiella Fernández, Joaquín
  • Posada González, David
Financiado para publicación en acceso aberto: Universidade de Vigo/CISUG, The genomic profiling of circulating tumor cells (CTCs) in the bloodstream should provide clinically relevant information on therapeutic efficacy and help predict cancer survival. Here, we contrasted the genomic profiles of CTC pools recovered from metastatic colorectal cancer (mCRC) patients using different enrichment strategies (CellSearch, Parsortix, and FACS). Mutations inferred in the CTC pools differed depending on the enrichment strategy and, in all cases, represented a subset of the mutations detected in the matched primary tumor samples. However, the CTC pools from Parsortix, and in part, CellSearch, showed diversity estimates, mutational signatures, and drug-suitability scores remarkably close to those found in matching primary tumor samples. In addition, FACS CTC pools were enriched in apparent sequencing artifacts, leading to much higher genomic diversity estimates. Our results highlight the utility of CTCs to assess the genomic heterogeneity of individual tumors and help clinicians prioritize drugs in mCRC., Agencia Estatal de Investigación | Ref. PID2019-106247GB-I00, Xunta de Galicia | Ref. ED481A-2018/303, Instituto de Salud Carlos III | Ref. PI17/00837, Instituto de Salud Carlos III | Ref. PI21/01771, Axencia Galega de Innovación | Ref. N607B-2020/02, Axencia Galega de Innovación | Ref. IN853B 2018/03
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

PolyDeep Advance 1: clinical validation of a computer-aided detection system for colorectal polyp detection with a second observer design

  • Davila Piñón, Pedro
  • Pedrido, Teresa
  • Díez Martín, Astrid Irene
  • Herrero, Jesús
  • Puga, Manuel
  • Rivas, Laura
  • Sánchez, Eloy
  • Zarraquiños, Sara
  • Pin, Noel
  • Vega, Pablo
  • Soto, Santiago
  • Remedios, David
  • Domínguez Carbajales, Rubén
  • Fernández Riverola, Florentino
  • Nogueira Rodríguez, Alba
  • González Peña, Daniel
  • Reboiro Jato, Miguel
  • López Fernández, Hugo
  • Cubiella, Joaquín
Background: PolyDeep is a computer-aided detection and characterization system that has demonstrated a high diagnostic yield for in vitro detection of colorectal polyps. Our objective is to compare the diagnostic performance of expert endoscopists and PolyDeep for colorectal polyp detection. Methods: PolyDeep Advance 1 (NCT05514301) is an unicentric diagnostic test study with a second observer design. Endoscopists performed colonoscopy blinded to PolyDeep’s detection results. The main endpoint was the sensitivity for colorectal polyp (adenoma, serrated or hyperplastic lesion) detection. The secondary endpoints were the diagnostic performance for diminutive lesions (≤5 mm), neoplasia (adenoma, serrated lesion) and adenoma detection. Results: We included 205 patients (55.1% male, 63.0 ± 6.2 years of age) referred to colonoscopy (positive faecal immunochemical occult blood test = 60.5%, surveillance colonoscopy = 39.5%). We excluded eight patients due to incomplete colonoscopy. Endoscopists detected 384 lesions, of which 39 were not detected by PolyDeep. In contrast, PolyDeep predicted 410 possible additional lesions, 26 of these predictions confirmed by endoscopists as lesions, resulting in a potential 6.8% detection increase with respect to the 384 lesions detected by the endoscopists. In total, 410 lesions were detected, 20 were not retrieved, five were colorectal adenocarcinoma, 343 were colorectal polyps (231 adenomas, 39 serrated and 73 hyperplastic polyps), 42 were normal mucosa and 289 were ≤5 mm. We did not find statistically significant differences between endoscopists and PolyDeep for colorectal polyp detection (Sensitivity = 94.2%, 91.5%, p = 0.2; Specificity = 9.5%, 14.3%, p = 0.7), diminutive lesions (Sensitivity = 92.3%, 89.5%, p = 0.4; Specificity = 9.8%, 14.6%, p = 0.7), neoplasia (Sensitivity = 95.2%, 92.9%, p = 0.3; Specificity = 9.6%, 13.9%, p = 0.4) and adenoma detection (Sensitivity = 94.4%, 92.6%, p = 0.5; Specificity = 7.2%, 11.8%, p = 0.2). Conclusions: Expert endoscopists and PolyDeep have similar diagnostic performance for colorectal polyp detection., Instituto de Salud Carlos III | Ref. CD22/00087, Instituto de Salud Carlos III | Ref. NT22/00009, Instituto de Salud Carlos III | Ref. FI22/00203, Agencia Estatal de Investigación | Ref. DPI2017-87494-R, Agencia Estatal de Investigación | Ref. PDC2021-121644-I00, Xunta de Galicia | Ref. ED431G 2019/06, Xunta de Galicia | Ref. ED431C 2022/03-GRC, Xunta de Galicia | Ref. ED481B-2023-005, Instituto de Salud Carlos III | Ref. PI21/01771